Stockscreener 앱 받기
1.48
0.67%
-0.01
시간 외 거래:
1.59
0.11
+7.43%
전일 마감가:
$1.49
열려 있는:
$1.5
하루 거래량:
133.13K
Relative Volume:
0.50
시가총액:
$44.50M
수익:
$210.70K
순이익/손실:
$-21.37M
주가수익비율:
-1.3455
EPS:
-1.1
순현금흐름:
$-21.10M
1주 성능:
+2.78%
1개월 성능:
-11.90%
6개월 성능:
-43.30%
1년 성능:
+53.05%
1일 변동 폭
$1.4622
$1.53
1주일 범위
$1.4137
$1.68
52주 변동 폭
$0.89
$3.19
게인 테라퓨틱스 Stock (GANX) Company Profile
명칭
Gain Therapeutics Inc
전화
(301) 500-1556
주소
4800 HAMPDEN LANE, BETHESDA
GANX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.48 | 53.41M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
게인 테라퓨틱스 Stock (GANX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-12-06 | 개시 | ROTH MKM | Buy |
| 2024-08-14 | 재개 | Oppenheimer | Outperform |
| 2021-04-12 | 개시 | BTIG Research | Buy |
| 2021-04-12 | 개시 | Oppenheimer | Outperform |
게인 테라퓨틱스 주식(GANX)의 최신 뉴스
Is Gain Therapeutics Inc. forming a reversal patternFree Safe Entry Stock Watch Suggestions - Newser
Candlestick signals on Gain Therapeutics Inc. stock todayPrice Action Based Buy Zone Forecast - Newser
Has Gain Therapeutics Inc. found a price floorFree Buy Signal Based on Chart Analysis - Newser
What analysts say about Gain Therapeutics Inc. stock outlookFree Daily Momentum Screener With Alerts - Newser
Healthcare Stocks in Focus: Gainers and Losers in Friday's After-Market Session - AInvest
Why Gain Therapeutics Inc. stock attracts strong analyst attentionFree Safe Entry Stock Watch Suggestions - Newser
Using flow based indicators on Gain Therapeutics Inc.Free Technical Stock Breakout Predictions - Newser
Visualizing Gain Therapeutics Inc. stock with heatmapsConsistent Return Setup with Exit Strategy - Newser
Best data tools to analyze Gain Therapeutics Inc. stockGrowth Watchlist for Long Term Positioning - Newser
Gain Therapeutics, Inc. (NASDAQ:GANX) Receives $8.20 Average Target Price from Analysts - Defense World
Gain Therapeutics (GANX) Projected to Post Earnings on Thursday - Defense World
What makes Gain Therapeutics Inc. stock price move sharplyGrowth Summary Based on Market Positioning - Newser
Analyzing recovery setups for Gain Therapeutics Inc. investorsPrice Forecast Based on AI Analysis - Newser
What technical models suggest about Alaunos Therapeutics Inc.’s comebackWeekly Signal Report with Trend Summary - Newser
What is the dividend policy of Gain Therapeutics Inc. stockConsistent wealth multiplication - Jammu Links News
Should I hold or sell Gain Therapeutics Inc. stock in 2025Discover breakthrough investment opportunities - Jammu Links News
Is Gain Therapeutics Inc. a good long term investmentAchieve breakthrough financial results today - Jammu Links News
Is Gain Therapeutics Inc. stock overvalued or undervaluedMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Gain Therapeutics Inc. stock higher in 2025Capitalize on high-yield stocks early - Jammu Links News
Evaluating Gain Therapeutics Inc. with trendline analysisPortfolio Review Summary with Five-Year Outlook - Newser
What are analysts’ price targets for Gain Therapeutics Inc. in the next 12 monthsHigh-velocity gains - Jammu Links News
How does Gain Therapeutics Inc. compare to its industry peersAccelerated capital growth - Jammu Links News
How does Gain Therapeutics Inc. generate profit in a changing economyConsistent triple returns - Jammu Links News
What are the latest earnings results for Gain Therapeutics Inc.Free Bull & Bear Market Updates - Jammu Links News
What is the risk reward ratio of investing in Gain Therapeutics Inc. stockMarket Forecast Updates That Work - Jammu Links News
RSI Reset May Fuel Rebound in Gain Therapeutics Inc.Smart Allocation Stock Pick Insights Gaining Interest - metal.it
Fibonacci Retracement Aligns with Support in Gain Therapeutics Inc.Market Surge Signal for Swing Traders Triggered - metal.it
게인 테라퓨틱스 (GANX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):